11 Results for "

IKK-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "IKK-IN-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13873
CAS No.: 406211-06-1
Purity:  95.02%
Target:  

IKK

Research Areas:  

Inflammation/Immunology

IKK-IN-1 is an inhibitor of IKK extracted from patent WO2002024679A1, compound example 18-13.
loading...
    loading...
Cat. No.: HY-146723
CAS No.: 2410423-31-1
Target:  

IKK

Research Areas:  

Inflammation/Immunology

IKKβ-IN-1 is a potent and orally active IkappaB (IKK-β) inhibitor with IC50 of 0.20 μM. IKKβ-IN-1 can reduce PGE2 and TNF-α production in mouse macrophage cells. IKKβ-IN-1 has the ability to protect mice against septic shock induced mortality [1].
loading...
    loading...
Cat. No.: HY-181271
CAS No.: 3035441-37-0
Target:  

IKK Autophagy

Research Areas:  

Cancer

IKKε-IN-1 is a IKKε inhibitor. IKKε-IN-1 reduces cell viability, inhibits colony formation and cell migration. IKKε-IN-1 induces autophagy (Autophagy) in cancer cells. IKKε-IN-1 can be used in the research of cancers including colorectal cancer, hepatocellular carcinoma, bladder cancer, breast cancer, lung cancer, and cervical cancer [1].
loading...
    loading...
38
38 Publications Verification
Cat. No.: HY-10519
CAS No.: 445430-58-0
Purity:  99.86%
Target:  

IKK

Research Areas:  

Cancer

BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
38
38 Publications Verification
Cat. No.: HY-10518
CAS No.: 547757-23-3
Purity:  99.90%
Target:  

IKK

Research Areas:  

Cancer

BMS-345541 hydrochloride is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
Cat. No.: HY-U00457
CAS No.: 2058264-32-5
Target:  

IKK

Research Areas:  

Cancer

TBK1/IKKε-IN-1 is a dual TBK1 and IKKε inhibitor extracted from patent US20160376283 A1, Compound 274 in Example 60, has IC50s of <100 nM.
loading...
    loading...
Cat. No.: HY-148206
CAS No.: 1623123-95-4
Target:  

IKK

Research Areas:  

Cancer

DMX-129 is an ΙΚΚε and TBK-1 inhibitor with IC50 values of <30 nM for both TBK1 and IKKε .
loading...
    loading...
Cat. No.: HY-138931
CAS No.: 2306877-20-1
Target:  

IKK

Research Areas:  

Cancer

TBK1/IKKε-IN-6 (example 110) is a TBK1 and IKKε inhibitor, with IC50 values of <100 nM for both TBK1 and IKKε .
loading...
    loading...
Cat. No.: HY-10518R
CAS No.: 547757-23-3
Target:  

Reference Standards IKK

Research Areas:  

Cancer

BMS-345541 hydrochloride (Standard) is the analytical standard of BMS-345541 hydrochloride (HY-10518). This product is intended for research and analytical applications. BMS-345541 hydrochloride is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
Cat. No.: HY-10519R
CAS No.: 445430-58-0
Target:  

Reference Standards IKK

Research Areas:  

Cancer

BMS-345541 (Standard) is the analytical standard of BMS-345541 (HY-10519). This product is intended for research and analytical applications. BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
Cat. No.: HY-L014
1,801 compounds

Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB. These proteins function as dimeric transcription factors that regulate the expression of genes and influence a broad range of biological processes including innate and adaptive immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis. NF-κB plays a key role in regulating the immune response to infection. In addition, activation of the NF-κB pathway is involved in the pathogenesis of chronic inflammatory diseases, such as asthma, rheumatoid arthritis, and inflammatory bowel disease. Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development.

MCE owns a unique collection of 1,801 small molecule compounds that can be used in the research of NF-κB signaling pathway or high throughput screening (HTS) related drug discovery.

  • 1